PERSPECTIVE THERAPEUTICS, INC.: 10-Q filed 2016-05-10
What PERSPECTIVE THERAPEUTICS, INC. reported in its quarterly report filed 2016-05-10 (fiscal Q3 2016): 27 published measures, 74 facts as tagged in accession 0001144204-16-100413.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2016-05-10
- Fiscal period
- fiscal Q3 2016
- Accession
- 0001144204-16-100413 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PERSPECTIVE THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 19,796,058 | USD | |
| At 2015-06-30 | 23,003,284 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 2,271,062 | USD | |
| At 2015-06-30 | 2,221,043 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 17,524,996 | USD | |
| At 2015-06-30 | 20,782,241 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 5,694,339 | USD | |
| At 2015-06-30 | 5,226,740 | USD | |
| At 2015-03-31 | 1,077,526 | USD | |
| At 2014-06-30 | 7,680,073 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | -1,195,297 | USD | 91 |
| 2015-07-01 to 2016-03-31 | -3,525,995 | USD | 275 |
| 2015-01-01 to 2015-03-31 | -953,553 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -2,646,369 | USD | 274 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2016-03-31 | 259,517 | USD | 275 |
| 2014-07-01 to 2015-03-31 | 77,963 | USD | 274 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | -65,257,502 | USD | |
| At 2015-06-30 | -61,731,507 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 415,675 | USD | |
| At 2015-06-30 | 574,840 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2016-03-31 | 229,442 | USD | 275 |
| 2014-07-01 to 2015-03-31 | 64,360 | USD | 274 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | -1,327,022 | USD | 91 |
| 2015-07-01 to 2016-03-31 | -3,828,077 | USD | 275 |
| 2015-01-01 to 2015-03-31 | -1,051,012 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -3,232,432 | USD | 274 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 13,240,163 | USD | |
| At 2015-06-30 | 16,325,522 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 0 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 950 | USD | 275 |
| 2015-01-01 to 2015-03-31 | 100 | USD | 90 |
| 2014-07-01 to 2015-03-31 | 3,551 | USD | 274 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 1,212,280 | USD | |
| At 2015-06-30 | 1,092,194 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 1,393,326 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 4,004,751 | USD | 275 |
| 2015-01-01 to 2015-03-31 | 1,106,209 | USD | 90 |
| 2014-07-01 to 2015-03-31 | 3,194,863 | USD | 274 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 457,291 | USD | |
| At 2015-06-30 | 403,955 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 66,304 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 176,674 | USD | 275 |
| 2015-01-01 to 2015-03-31 | 55,197 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -37,569 | USD | 274 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 183,187 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 385,325 | USD | 275 |
| 2015-01-01 to 2015-03-31 | 141,399 | USD | 90 |
| 2014-07-01 to 2015-03-31 | 458,636 | USD | 274 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 55,010,619 | shares | |
| At 2015-06-30 | 54,967,559 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 7,898,120 | USD | |
| At 2015-06-30 | 7,689,676 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 7,482,445 | USD | |
| At 2015-06-30 | 7,114,836 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 222,529 | USD | |
| At 2015-06-30 | 245,031 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2016-03-31 | 288,977 | USD | |
| At 2015-06-30 | 263,597 | USD |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | -1,197,955 | USD | 91 |
| 2015-07-01 to 2016-03-31 | -3,533,969 | USD | 275 |
| 2015-01-01 to 2015-03-31 | -956,211 | USD | 90 |
| 2014-07-01 to 2015-03-31 | -2,654,343 | USD | 274 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 909,144 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 2,785,539 | USD | 275 |
| 2015-01-01 to 2015-03-31 | 589,934 | USD | 90 |
| 2014-07-01 to 2015-03-31 | 1,703,825 | USD | 274 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2016-01-01 to 2016-03-31 | 131,725 | USD | 91 |
| 2015-07-01 to 2016-03-31 | 302,082 | USD | 275 |
| 2015-01-01 to 2015-03-31 | 97,459 | USD | 90 |
| 2014-07-01 to 2015-03-31 | 586,063 | USD | 274 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2016-03-31 | -165,339 | USD | 275 |
| 2014-07-01 to 2015-03-31 | 116,817 | USD | 274 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2016-03-31 | 125,536 | USD | 275 |
| 2014-07-01 to 2015-03-31 | 104,818 | USD | 274 |
Inspect the source
- Entity
- PERSPECTIVE THERAPEUTICS, INC. / CIK 0000728387
- Captured
- 2026-09-19T15:00:29.793Z
- SEC response SHA-256
80792777921b49454c9d29f110283a1024ec5ce2a3749610d4c1319da49650fe
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000728387.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))